Barbara A. Cornblatt
#69,231
Most Influential Person Now
American psychologist
Barbara A. Cornblatt's AcademicInfluence.com Rankings
Barbara A. Cornblattpsychology Degrees
Psychology
#2162
World Rank
#2525
Historical Rank
#1100
USA Rank
Clinical Psychology
#260
World Rank
#264
Historical Rank
#101
USA Rank
Download Badge
Psychology
Why Is Barbara A. Cornblatt Influential?
(Suggest an Edit or Addition)According to Wikipedia, Barbara A. Cornblatt is Professor of Psychiatry and Molecular Medicine at Hofstra Northwell School of Medicine. She is known for her research on serious mental disorders, with a specific focus on psychosis and schizophrenia. Her efforts to find treatments to help youth with mental illness led to the development of the Recognition and Prevention Program, which she founded in 1998.
Barbara A. Cornblatt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. (2008) (1268)
- The psychosis high-risk state: a comprehensive state-of-the-art review. (2013) (1197)
- Impaired attention, genetics, and the pathophysiology of schizophrenia. (1994) (697)
- The continuous performance test, identical pairs version (CPT-IP): I. new findings about sustained attention in normal families (1988) (678)
- Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. (2000) (513)
- Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. (2007) (493)
- At clinical high risk for psychosis: outcome for nonconverters. (2011) (432)
- The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients (1989) (415)
- NEUROPSYCHOLOGY OF THE PRODROME TO PSYCHOSIS IN THE NAPLS CONSORTIUM: RELATIONSHIP TO FAMILY HISTORY AND CONVERSION TO PSYCHOSIS (2008) (415)
- Generalized and Specific Neurocognitive Deficits in Prodromal Schizophrenia (2006) (408)
- An Individualized Risk Calculator for Research in Prodromal Psychosis. (2016) (403)
- Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. (2009) (403)
- The schizophrenia prodrome revisited: a neurodevelopmental perspective. (2003) (390)
- Cognitive and behavioral precursors of schizophrenia (1999) (318)
- Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity. (1985) (288)
- North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. (2007) (277)
- Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. (2005) (261)
- Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. (2015) (258)
- Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. (2001) (237)
- Sustained attention in children at risk for schizophrenia. Report on a continuous performance test. (1977) (225)
- Risk factors for psychosis: impaired social and role functioning. (2012) (224)
- Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. (2007) (218)
- North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment (2012) (218)
- Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia (2004) (213)
- High dose D-serine in the treatment of schizophrenia (2010) (210)
- Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study (2013) (207)
- Prediction of functional outcome in individuals at clinical high risk for psychosis. (2013) (199)
- Research in people with psychosis risk syndrome: a review of the current evidence and future directions. (2010) (193)
- Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. (2016) (193)
- Positive and negative schizophrenic symptoms, attention, and information processing. (1985) (183)
- Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project (2014) (180)
- Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. (2007) (178)
- Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. (2011) (176)
- The schizophrenia prodrome: treatment and high-risk perspectives (2002) (168)
- Schizotypy and sustained attention. (1991) (168)
- North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms (2015) (163)
- The New York High-Risk Project. Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up. (1997) (162)
- The MATRICS Consensus Cognitive Battery in Patients with Bipolar I Disorder (2011) (161)
- The New York High-Risk Project. (1984) (157)
- Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies. (2005) (149)
- The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. (2014) (141)
- The psychosis risk syndrome and its proposed inclusion in the DSM-V: A risk–benefit analysis (2010) (139)
- The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology. (1993) (139)
- Childhood Attentional Dysfunctions Predict Social Deficits in Unaffected Adults at Risk for Schizophrenia (1992) (139)
- Treatment of the schizophrenia prodrome: is it presently ethical? (2001) (135)
- The New York High-Risk Project: a followup report. (1987) (135)
- Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program. (2015) (132)
- The New York High-Risk Project. Psychoses and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up. (1995) (130)
- The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine (2006) (127)
- Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project. (2016) (126)
- The New York high risk project to the Hillside recognition and prevention (RAP) program. (2002) (126)
- Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization (2018) (123)
- Multisite reliability of MR-based functional connectivity (2017) (121)
- D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial. (2015) (119)
- High-risk research in schizophrenia: a summary of what has been learned. (1987) (118)
- Childhood precursors of affective vs. social deficits in adolescents at risk for schizophrenia. (1993) (116)
- A summary of attentional findings in the New York High-Risk Project. (1992) (116)
- Attentional measures in a study of children at high-risk for schizophrenia. (1978) (115)
- Early identification and high-risk strategies for bipolar disorder. (2007) (114)
- The empirical status of the ultra high-risk (prodromal) research paradigm. (2007) (108)
- Attentional abilities and measures of schizotypy: Their variation and covariation in schizophrenic patients, their siblings, and normal control subjects (1994) (106)
- Early traumatic experiences in those at clinical high risk for psychosis (2013) (100)
- Toxocara canis infection of children: epidemiologic and neuropsychologic findings. (1987) (99)
- Whither the attenuated psychosis syndrome? (2012) (97)
- Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities (2005) (96)
- Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial (2014) (95)
- A taxometric analysis of cognitive and neuromotor variables in children at risk for schizophrenia. (1989) (94)
- Spatial working memory deficits in adolescents at clinical high risk for schizophrenia (2006) (93)
- Eye-tracking dysfunction in offspring from the New York High-Risk Project: diagnostic specificity and the role of attention (1997) (90)
- Cognitive brain potential components in adolescents. (1984) (89)
- Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode (2014) (86)
- Substance use in clinical high risk for psychosis: a review of the literature (2014) (85)
- HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia (2012) (83)
- Social Competence Deficits in Adolescents at Risk for Schizophrenia (1994) (83)
- Update of high-risk research: 1987-1997 (1997) (82)
- The assessment of "prodromal schizophrenia": unresolved issues and future directions. (2003) (82)
- Attentional functioning in schizotypal personality disorder. (1997) (80)
- Comorbid diagnoses for youth at clinical high risk of psychosis (2017) (80)
- Hillside study of risk and early detection in schizophrenia (1998) (79)
- Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk (2018) (79)
- The New York High-Risk Project: attention, anhedonia and social outcome (1998) (78)
- Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome (2012) (72)
- Wisconsin Card Sorting deficits in the offspring of schizophrenics in the New York High-Risk Project (2002) (71)
- Premorbid functional development and conversion to psychosis in clinical high-risk youths (2013) (71)
- The Bipolar Prodrome Symptom Interview and Scale–Prospective (BPSS‐P): description and validation in a psychiatric sample and healthy controls (2014) (71)
- Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis. (2015) (70)
- Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. (2019) (70)
- Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: A preliminary study (2012) (69)
- The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: A naturalistic study of the North American Prodrome Longitudinal Sample (2009) (66)
- Social competence and positive and negative symptoms: a longitudinal study of children and adolescents at risk for schizophrenia and affective disorder. (1991) (66)
- Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis (2014) (66)
- Progress in experimental personality & psychopathology research (1992) (66)
- Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome. (2016) (66)
- The continuous performance test, identical pairs version (CPT-IP) : III: Brain functioning during performance of numbers and shapes subtasks (1997) (65)
- Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis. (2017) (65)
- Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study (2015) (63)
- Attention and Clinical Symptoms in Schizophrenia (2004) (63)
- From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline. (2018) (63)
- Anxiety in youth at clinical high risk for psychosis (2017) (62)
- Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia. (2008) (60)
- Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the North American Prodrome Longitudinal Study (NAPLS) (2014) (58)
- Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome (2010) (58)
- Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis (2018) (57)
- Neuroprotection in emerging psychotic disorders (2007) (56)
- Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome (2013) (55)
- Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis (2016) (54)
- An assessment of cognitive function and mood in chronic fatigue syndrome (1996) (54)
- Event-related potentials in children at risk for schizophrenia during two versions of the continuous performance test (1986) (54)
- Psychometric deviance in offspring at risk for schizophrenia: I. Initial delineation of a distinct subgroup (1990) (52)
- Theory of mind, emotion recognition and social perception in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort (2015) (50)
- Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort (2010) (50)
- Sustained attention in combat-related posttraumatic stress disorder (1997) (49)
- Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: Analysis from the North American Prodrome Longitudinal Study (2014) (48)
- A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program (2017) (47)
- Substance use in individuals at clinical high risk of psychosis (2015) (45)
- Current status specifiers for patients at clinical high risk for psychosis (2014) (43)
- Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis (2015) (43)
- Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis (2019) (41)
- Auditory event-related potentials in children at risk for schizophrenia: The complete initial sample (1988) (41)
- Prospective study of adolescents with subsyndromal psychosis: characteristics and outcome. (2005) (41)
- Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high‐risk sample (2015) (41)
- Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups (2018) (41)
- Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. (2019) (39)
- Effects of Galantamine on Measures of Attention: Results From 2 Clinical Trials in Alzheimer Disease Patients With Comparisons to Donepezil (2008) (39)
- The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. (2018) (38)
- Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort (2019) (38)
- Assessing the potential to use neurocognition to predict who is at risk for developing bipolar disorder: A review of the literature (2013) (38)
- Severity of thought disorder predicts psychosis in persons at clinical high-risk (2015) (38)
- Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort (2017) (38)
- Positive and negative symptoms and social competence in adolescents at risk for schizophrenia and affective disorder. (1990) (36)
- Toward Leveraging Human Connectomic Data in Large Consortia: Generalizability of fMRI‐Based Brain Graphs Across Sites, Sessions, and Paradigms (2019) (35)
- Biobehavioral risk factors in children of schizophrenic parents (1984) (34)
- Neurodevelopmental models of schizophrenia: pathophysiologic synthesis and directions for intervention research. (2001) (33)
- Psychotropic medication use in youth at high risk for psychosis: Comparison of baseline data from two research cohorts 1998–2005 and 2008–2011 (2013) (33)
- The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis (2015) (33)
- Perceived discrimination in those at clinical high risk for psychosis (2014) (32)
- High-Risk Research in Schizophrenia (1979) (32)
- “Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate (2011) (31)
- Auditory recognition memory in adolescents at risk for schizophrenia: Report on a verbal continuous recognition task (1980) (30)
- Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosis (2012) (30)
- Neurocognitive benefits of aripiprazole versus olanzapine in stable psychosis (2002) (30)
- Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit (2020) (29)
- Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis (2017) (28)
- Transition to schizophrenia and related disorders: toward a taxonomy of risk. (2003) (27)
- Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium (2015) (27)
- Early-onset schizophrenia is associated with impaired adolescent development of attentional capacity using the identical pairs continuous performance test (2006) (27)
- Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis (2017) (26)
- Core Schemas in Youth at Clinical High Risk for Psychosis (2015) (26)
- Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services. (2019) (26)
- Eye tracking dysfunctions in offspring from the new york high risk project: Diagnostic specificity and the role of attention (1995) (26)
- Using the global functioning social and role scales in a first‐episode sample (2011) (25)
- Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis (2016) (25)
- Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium (2019) (25)
- Distractibility in schizophrenia (1995) (25)
- Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. (2020) (24)
- 23. Omega-3 Fatty Acid Versus Placebo in a Clinical High-Risk Sample From the North American Prodrome Longitudinal Studies (NAPLS) Consortium (2017) (24)
- Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion among Clinically High-Risk Youth Developing Psychotic Disorders (2015) (24)
- Standardizing the use of the Continuous Performance Test in schizophrenia research: A validation study (2012) (23)
- Electrodermal recovery data on children of schizophrenic parents (1985) (23)
- Early Detection, Intervention, and Prevention of Psychosis Program: Rationale, Design, and Sample Description (2012) (23)
- 24.2 NEUROCOGNITIVE PROFILES IN THE PRODROME TO PSYCHOSIS IN NAPLS-1 (2018) (22)
- Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders. (2015) (22)
- Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program (2017) (22)
- Stress perception following childhood adversity: Unique associations with adversity type and sex (2019) (21)
- Treating early psychosis: who, what, and when? (2005) (21)
- Paliperidone extended‐release tablets in patients with recently diagnosed schizophrenia (2010) (21)
- Self‐awareness of functional impairment in individuals at clinical high‐risk for psychosis (2015) (20)
- Insights into psychosis risk from leukocyte microRNA expression (2016) (20)
- Refining phenotype characterization in genetic linkage studies of schizophrenia. (1991) (20)
- Treatment of the Schizophrenia Prodrome (2004) (20)
- Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort (2018) (19)
- Report of a workshop on genetic linkage studies in schizophrenia. (1990) (19)
- Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis (2019) (19)
- Deconstructing the Psychosis Risk Syndrome: Moving the Field of Prevention Forward. (2016) (19)
- Neurocognitive effects: aripiprazole vs olanzapine in stable psychosis (2002) (18)
- Early Detection, Intervention and Prevention of Psychosis Program: Community Outreach and Early Identification at Six U.S. Sites. (2016) (18)
- Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers (2016) (18)
- Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. (2016) (17)
- Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome (2017) (17)
- Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis (2015) (17)
- Networks of blood proteins in the neuroimmunology of schizophrenia (2018) (16)
- Predictive validity of conversion from the clinical high risk syndrome to frank psychosis (2019) (16)
- Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort (2020) (16)
- 6 – The Prediction of Psychiatric Disorders in Late Adolescence (1991) (15)
- Demographic correlates of attenuated positive psychotic symptoms (2015) (14)
- Pharmacological treatment of cognition in schizophrenia: an idea whose method has come. (2008) (14)
- Bipolar Prodrome Symptom Scale - Abbreviated Screen for Patients: Description and validation. (2019) (14)
- Cognitive function with long-term risperidone in children and adolescents with disruptive behavior disorder. (2009) (14)
- Eye tracking dysfunction in offspring from the New York high-risk project (1995) (13)
- The Role of microRNA Expression in Cortical Development During Conversion to Psychosis (2017) (13)
- Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study (2018) (13)
- The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis (2016) (13)
- Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study (2019) (12)
- Tobacco use and psychosis risk in persons at clinical high risk (2017) (12)
- Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort (2021) (12)
- Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome (2020) (12)
- Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk. (2018) (12)
- The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning (2019) (12)
- Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis (2019) (12)
- The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning (2018) (11)
- White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis (2021) (10)
- Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales (2017) (10)
- Changes in symptom content from a clinical high‐risk state to conversion to psychosis (2019) (10)
- Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis (2019) (10)
- Overview of the First Annual Workshop on the Schizophrenia Prodrome. (2003) (10)
- Methylphenidate salivary levels in children. (1987) (10)
- Exploration of clinical high-risk dropouts (2017) (10)
- PERSONALITY FEATURES AND DISORDER IN THE SUBJECTS IN THE NEW YORK HIGH-RISK PROJECT. (1993) (10)
- Stability of mismatch negativity event‐related potentials in a multisite study (2020) (10)
- Duration of the psychosis prodrome (2019) (9)
- The role of a family history of psychosis for youth at clinical high risk of psychosis (2019) (9)
- Changes in the Late Task‐Related Brain Potentials during Adolescence a (1984) (9)
- Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study (2019) (9)
- Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator (2020) (9)
- Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis. (2022) (8)
- Cognitive behavioural social skills training: Methods of a randomized controlled trial for youth at risk of psychosis (2021) (8)
- The field of schizophrenia: strengths, weaknesses, opportunities, and threats. (2012) (8)
- Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD (2019) (8)
- A prospective study of children of schizophrenic parents (1980) (8)
- Schizophrenia Etiology and Neurocognition (2008) (8)
- The Timing of Neurodevelopmental Abnormality in Schizophrenia: An Integrative Review of the Neuroimaging Literature (2001) (8)
- Attention deficits in the development of schizophrenia: Recent evidence from genetic high-risk and prodromal studies (2005) (7)
- Between-site reliability of startle prepulse inhibition across two early psychosis consortia (2013) (6)
- Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects study (2019) (6)
- Sleep Disturbance in Individuals at Clinical High Risk for Psychosis. (2021) (6)
- Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents. (2020) (6)
- Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms (2020) (6)
- The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis (2018) (5)
- Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study (2021) (5)
- High-risk research in schizophrenia: New strategies, new designs. (1998) (5)
- SEX DIFFERENCES IN SYMPTOM PRESENTATION IN INDIVIDUALS AT RISK FOR PSYCHOSIS (2010) (5)
- 5. The “high risk” paradigm: Childhood predictors of schizophrenic disorders (1996) (5)
- DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders (2020) (5)
- Cross-paradigm connectivity: reliability, stability, and utility (2020) (5)
- Deficits in Auditory Predictive Coding in Individuals With the Psychosis Risk Syndrome: Prediction of Conversion to Psychosis (2020) (5)
- CLINICAL HIGH RISK FOR PSYCHOSIS: THE RISK OF FALSE POSITIVE (2010) (4)
- Advances in early detection, treatment and prevention: Findings from the North American Prodrome Longitudinal Study (2008) (4)
- Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk (2022) (4)
- Depression: An actionable outcome for those at clinical high-risk (2020) (4)
- The Association Between Neighborhood Poverty and Hippocampal Volume Among Individuals at Clinical High-Risk for Psychosis: The Moderating Role of Social Engagement. (2022) (4)
- Attention and schizophrenia (1989) (4)
- Patterns and perceptions of face-to-face and digital communication in the clinical high risk and early stages of psychosis (2019) (4)
- Early intervention in psychosis: Rationale, results and implications for treatment of adolescents at risk. (2012) (4)
- Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. (2020) (4)
- F32. DIFFERENCES BETWEEN YOUTH AT CLINICAL HIGH-RISK FOR PSYCHOSIS WHO DO NOT TRANSITION TO PSYCHOSIS: THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY (NAPLS-2) (2018) (4)
- S102. COGNITIVE-BEHAVIORAL SOCIAL SKILLS TRAINING IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS: QUANTITATIVE AND QUALITATIVE METHODS: FOR IMPLEMENTATION AND FACILITATOR TRAINING (2019) (4)
- Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study (2021) (3)
- O33. EEG Alpha Event-Related Desynchronization Deficits Predict Conversion to Psychosis in Individuals With the Psychosis Risk Syndrome (2019) (3)
- Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium (2021) (3)
- Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis (2020) (3)
- Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis (2020) (3)
- Bullying and social functioning, schemas, and beliefs among youth at clinical high risk for psychosis (2021) (3)
- The association between migrant status and transition in an ultra-high risk for psychosis population (2021) (3)
- Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes. (2022) (3)
- Editors' Introduction: New Frontiers in Prodromal Research (2003) (3)
- Negative symptoms: associations with defeatist beliefs, self-efficacy, and maladaptive schemas in youth and young adults at-risk for psychosis (2021) (3)
- Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis (2022) (3)
- USING THE GLOBAL FUNCTIONING SOCIAL AND ROLE SCALES IN A FIRST EPISODE SAMPLE (2010) (3)
- The New York high-risk project: Comorbidity of axis I disorders in subjects at high risk for schizophrenia or major affective disorders and in low-risk subjects (1991) (3)
- SU127. Negative Symptoms in Youth at Clinical High Risk of Psychosis (2017) (3)
- The new york high-risk project: Psychoses in the adult offspring of schizophrenic parents (1995) (2)
- O3.2. BRAIN HYPERACTIVATION DURING MEMORY RETRIEVAL PRECEDES AND PREDICTS CONVERSION TO PSYCHOSIS IN INDIVIDUALS AT CLINICAL HIGH RISK (2018) (2)
- Axis II personality features and disorder in subjects in the New York high-risk project (1991) (2)
- Expanding the Boundaries of Early Intervention for Psychosis: Intervening During the Prodrome (2008) (2)
- 209. Risk of Violence in Attenuated Psychosis Symptoms Syndrome and its Relationship With Symptomology. (2017) (2)
- Attenuated negative symptoms in individuals at clinical high risk for psychosis (2013) (2)
- At Risk Mental State and Prediction (2009) (2)
- Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis (2021) (2)
- NAPLS: SOCIAL FUNCTIONING FOUND TO BE A STABLE TRAIT AND A PREDICTOR OF PSYCHOSIS (2008) (2)
- Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis. (2021) (2)
- The schizophrenia prodrome: promise for prevention (2001) (2)
- F202. Atypical P300 Amplitude Differentiates Conversion Patterns in Psychosis Prodrome When Autism Spectrum Disorder is Comorbid (2018) (2)
- Multiple microcomputers for data entry and analysis. (1987) (2)
- 279. The hillside rapp clinic: intervention during the schizophrenia prodrome (1998) (2)
- The genetics of mental illness: An overview (1991) (2)
- Mismatch Negativity Abnormalities Are Associated with Poorer Functioning in Youth at Clinical High Risk for Psychosis: Evidence from the NAPLS Study (2013) (2)
- The hillside study of risk and early detection in schizophrenia: Early findings (1998) (2)
- Family history of psychosis in youth at clinical high risk: A replication study (2022) (2)
- Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm (2020) (2)
- 116 Evaluation of the effectiveness of early predictors of schizophrenia spectrum disorders in the New York high-risk project (1997) (2)
- Cognitive-Behavioral Social Skills Training Adapted for Youth at Clinical High Risk for Psychosis. (2022) (1)
- Anxiety in youth at clinical high-risk for psychosis: A two-year follow-up (2021) (1)
- THE NEUROPSYCHOLOGY OF THE PRODROME TO PSYCHOSIS IN THE NAPLS STUDY: RELATIONSHIP TO FAMILY HISTORY AND CONVERSION TO PSYCHOSIS (2008) (1)
- WC8C NAPLS CONSORTIUM: IMPAIRED SOCIAL, SCHOOL, AND WORK FUNCTIONING CHARACTERIZES PRODROMAL INDIVIDUALS PRIOR TO EMERGENCE OF PSYCHOSIS (2006) (1)
- Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort (2022) (1)
- F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER (2018) (1)
- 20. Metabolic Abnormalities and Omega-3 Fatty Acids in Latinos at Clinical High Risk for Psychosis. (2017) (1)
- Greater Prepulse Inhibition Prior to the Onset of Psychosis? Findings from the North American Prodrome Longitudinal Study Consortium (2011) (1)
- Etiology and Neurocognition (2008) (1)
- Neuropsychological deficits in adolescents and adult schizophrenics (1994) (1)
- Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort (2022) (1)
- Neurodevelopment and Schizophrenia: Developmental models and hypothesis-driven early interventions in schizophrenia (2004) (1)
- The immediate impact of the COVID-19 pandemic on attenuated positive symptoms and functioning in individuals at clinical high risk for psychosis: A pilot study (2021) (1)
- Bipolar Prodrome Symptom Scale: Abbreviated Screen for Patients (2019) (1)
- S184. MACHINE LEARNING REVEALS DEVIANCE IN NEUROANATOMICAL MATURITY PREDICTIVE OF FUTURE PSYCHOSIS IN YOUTH AT CLINICAL HIGH RISK (2018) (1)
- 97. The hillside RAPP clinic: why the sudden interest in the schizophrenia prodrome? (2000) (1)
- The associations between area-level residential instability and gray matter volumes from the North American Prodrome Longitudinal Study (NAPLS) consortium (2022) (1)
- O5.6. ADVANCED DIFFUSION IMAGING IN PSYCHOSIS RISK: A CROSS-SECTIONAL AND LONGITUDINAL STUDY OF WHITE MATTER DEVELOPMENT (2020) (1)
- Self-reported functional impairment in individuals at clinical high-risk for psychosis (2013) (1)
- Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis (2021) (1)
- Eye-movement dysfunctions in schizophrenia: State or trait? (1995) (1)
- THE PSYCHOSIS HIGH RISK STATE: IS IT VALID? (2014) (1)
- Toward leveraging big data in human functional connectomics: Generalization of brain graphs across scanners, sessions, and paradigms (2017) (1)
- Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosis (2023) (1)
- ANTI-DEPRESSANTS: AN EFFECTIVE TREATMENT FOR THE PRODROMAL PHASE OF SCHIZOPHRENIA? (2008) (1)
- Predicting schizophrenia (1995) (1)
- 95. Smooth pursuit eye movement dysfunction in patients at clinical risk for schizophrenia (2000) (1)
- 39.1 DNA METHYLATION OF IMMUNE CELLS IN PERSONS AT CLINICAL HIGH RISK FOR PSYCHOSIS (2018) (0)
- P300 event-related potential components and axis II-schizophrenia-related features and disorders (1991) (0)
- Healthy Adolescent Performance on the MATRICS Cognitive Consensus Battery (MCCB): Developmental Data from Two Samples of Volunteers (2017) (0)
- The New York high-risk project: History of study, overview of marker findings to date and prevalence of axis I high and low risk subjects (1991) (0)
- Migrant status, clinical symptoms and functional outcome in youth at clinical high risk for psychosis: findings from the NAPLS-3 study (2022) (0)
- Face-to-Face and Digital Communication Questionnaire (2020) (0)
- 408. Associations Between Area-Level Social Fragmentation During Childhood, Discrimination, and Lower Positive Core Schemas in Healthy Controls and Clinical High Risk for Psychosis Participants (2023) (0)
- Clinical status of early-onset adolescent psychotic in-patients (1994) (0)
- 100. Converging Evidence for Social Functioning Deficits as a Neurodevelopmental Risk Factor in High-Risk Youth (2017) (0)
- S244. CHARACTERIZING OUTCOMES OF CLINICAL HIGH-RISK NON-CONVERTERS USING GROUP-BASED TRAJECTORY MODELING (2018) (0)
- Wisconsin card sorting in the young adult offspring of schizophrenics (1995) (0)
- S-37-2 Childhood predictors of schizotypal features in non-psychotic adults (1996) (0)
- Faculty Opinions recommendation of [CONFERENCE POSTER]: Comorbid anxiety and short-term clinical outcome in first episode psychosis. (2011) (0)
- Eye-movement dysfunctions and the neurodevelopmental view of schizophrenia (1995) (0)
- Children at High Risk for Schizophrenia: Predictions From Infancy to Childhood Functioning (2021) (0)
- 192. Different Age-Related Trajectories of Social Cognition in Youths at Clinical High Risk of Psychosis (2017) (0)
- Life Event Stress and Reduced Cortical Thickness in Youth at Clinical High-Risk for Psychosis and Healthy Youths. (2021) (0)
- 301 Amphetamine and cognitive impairment in schizotypal personality disorder (1997) (0)
- F236. Association of Baseline Tumor Necrosis Factor and the Development of Negative Symptoms in Individuals at Clinical High Risk for Psychosis (2018) (0)
- Fine motor coordination in subjects at risk for schizophrenia (1993) (0)
- O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY (2020) (0)
- Adolescent-onset psychosis and the schizophrenia spectrum (1994) (0)
- 216. Are attention and symptoms independent in children at risk for schizophrenia? (1998) (0)
- The association between area-level residential instability and gray matter volume changes (2022) (0)
- 11. The Association Between Ethnic Minority Density During Childhood and Cortical Thickness: The Moderating Role of Social Engagement Among Minority Youth (2023) (0)
- The New York high-risk project: Major axis I disorders in the adult offspring of schizophrenic parents (1995) (0)
- Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis (2023) (0)
- 315. Disease-Informed Assessment Identifies Robust Brain Correlates of Cognitive Performance in Psychosis and its Prodrome (2023) (0)
- P535. Neighborhood Poverty and Hippocampal Volume Among Individuals at Clinical High Risk for Psychosis: The Moderating Role of Social Engagement (2022) (0)
- TC15E HPA AXIS REACTIVITY IN PRODROMAL PATIENTS AND POSITIVE SYMPTOMS (2006) (0)
- Neurocognition as a Biomarker for Psychosis Onset: Exploring the Impact of Age (2022) (0)
- 280. Effects of amphetamine on cognitive impairment in schizotypal personality disorder (1996) (0)
- T13. THE ASSOCIATION BETWEEN CHILDHOOD TRAUMA AND INFLAMMATION IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS (2019) (0)
- Attentional markers of schizophrenia: New evidence from New York high risk project and elmhurst adolescent project (1995) (0)
- Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization (2018) (0)
- 8. Reinterpretation of schizophrenia: The question of neurocognitive heterogeneity (1998) (0)
- Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium. (2023) (0)
- F61. TRIVIAL TRANSITIONS? SIPS-DEFINED CONVERSIONS TO PSYCHOSIS: ONE YEAR OUTCOME (2019) (0)
- Measuring neurocognitive change (1994) (0)
- P586. Relation of Regional Cortical Thickness and Surface Area With General Cognitive Abilities in Psychosis-Risk (2022) (0)
- 59.4 Networks of Blood Analytes are Collectively Informative of Risk of Conversion to Schizophrenia. (2017) (0)
- Sampling from different populations: Sociodemographic, clinical, and functional differences between samples of first episode psychosis individuals and clinical high-risk individuals who progressed to psychosis (2023) (0)
- Title: Linking Choroid Plexus Enlargement with Plasma Analyte and Structural Phenotypes in Clinical High Risk for Psychosis: A Multisite Neuroimaging Study Short Title: Choroid Plexus Enlargement in Clinical High Risk for Psychosis (2022) (0)
- WC8D THE DEVELOPMENT OF THE NAPLS DATASET AND BASELINE SAMPLE CHARACTERISTICS (2006) (0)
- 278. Clinical and neuropsychological deficits in bipolar and schizophrenic patients (1996) (0)
- Faculty Opinions recommendation of Prediction of psychosis by mismatch negativity. (2011) (0)
- Onset and premorbid clinical features of psychosis in the New York high-risk project (1991) (0)
- 133. Dynamic Prediction of Outcomes for Youth at Clinical High-Risk for Psychosis: A Joint Modeling Approach (2023) (0)
- 352. Resource Utilization and Comorbidity in Clinical High-Risk Individuals in the North American Prodrome Longitudinal Studies (NAPLS) 3 Cohort (2023) (0)
- Eye-tracking dysfunctions—A biobehavioral marker of susceptibility to schizophrenia (1998) (0)
- WC8B NEUROCOGNITIVE FUNCTIONING IN THE PRODROME TO PSYCHOSIS FROM THE NAPLS COLLABORATION (2006) (0)
- Acknowledgement to assessors (2014) (0)
- 8. Risk and protective factors across the schizophrenia spectrum (1996) (0)
- 244. Improvement in working memory in schizotypal subjects following physostigmine (1996) (0)
- 377. Neurocognitive profiles of siblings at risk for schizophrenia (1998) (0)
- The autonomic orienting response in schizophrenia and mania (1994) (0)
- 14. Frequency of Cannabis-Use, Neurocognitive Performance and Functioning in Clinical High-Risk Participants From the NAPLS-3 Cohort: Moderate Use is Associated With Better Performance and Functioning (2023) (0)
- TK3 THE CLINICAL HIGH RISK PARADIGM (2006) (0)
- Cross-paradigm connectivity: reliability, stability, and utility (2020) (0)
- Severity of baseline positive symptoms predicts psychosis in adolescents prodromal for schizophrenia (2003) (0)
- S21. THE IMPACT OF PERSISTENT NEGATIVE SYMPTOMS ON FUNCTIONING AND DEFEATIST BELIEFS IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS (2019) (0)
- Gamma Oscillations and Excitation/Inhibition Imbalance: Parallel Effects of NMDA Receptor Antagonism and the Psychosis Risk Syndrome (2020) (0)
- S-37-3 Neurobiologyy of the schizophrenia spectrum (1996) (0)
- Attentional dysfunction in schizotypal personality disorder (1995) (0)
- A t C linical H igh R isk for P sychosis: ou tcom e for N onconverters (2011) (0)
- S0033291718002258jra 1670..1677 (2019) (0)
- Hippocampal Connectivity With the Default Mode Network Is Linked to Hippocampal Volume in the Clinical High Risk for Psychosis Syndrome and Healthy Individuals (2023) (0)
- Children at High Risk for Schizophrenia: Predictions from Childhood to Adolescence (2021) (0)
- Bipolar Prodrome Symptom Scale--Retrospective Version (2020) (0)
- T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS (2020) (0)
- O9.8. STRESS AND COGNITIVE FUNCTION AMONG INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS: FINDINGS FROM THE NAPLS COHORT (2018) (0)
- Im pact of N eurocognition on Social and R ole Functioning in Ind ivid uals at Clinical H igh R isk for P sychosis (2011) (0)
- Support for a neurodevelopmental view of schizophrenia (1995) (0)
- Treatment approaches in the psychosis prodrome (2020) (0)
- PRODROMAL SYMPTOMS: DIFFERENTIAL EFFECTS OF SEX AND FAMILY HISTORY (2010) (0)
- Poster #131 PREDICTION OF FUNCTIONAL OUTCOME IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS (2012) (0)
- S190. Does Cannabis Use Interact With Neurophysiological Vulnerability in the Early Expression of Psychosis and Conversion Status in Clinical High-Risk (CHR) Individuals? (2019) (0)
- 80. Auditory Target Processing Deficits in Individuals at Clinical High Risk for Psychosis (2017) (0)
- Schizophrenia: All Pathways to Symptoms Pass Through Cognitive Deficits? (1996) (0)
- M118. Functional Capacity: A New Predictor of Role Functioning in Individuals at Clinical High Risk for Psychosis (2017) (0)
- O2.8. TRAJECTORIES OF NEUROCOGNITIVE FUNCTIONING OVER TIME IN YOUTH AT CLINICAL HIGH RISK WHO DO AND DO NOT TRANSITION TO PSYCHOSIS (2018) (0)
- Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis. (2022) (0)
- Two studies of attentional processing in schizotypal personality disorder (2003) (0)
- 93. Behavioral profiles of adolescents putatively prodromal for schizophrenia (2000) (0)
- 98. A self-report questionnaire to screen for prodromal schizophrenia (2000) (0)
- S57. Does the Acquisition of Social Cognitive Skills Over Adolescence Coincide With Neurophysiological Metric of Brain Maturation? A Cross-Sectional Analysis of the NAPLS-II Consortium Sample (2019) (0)
- 251. Attentional and eye movement dysfunctions in schizophrenia (1996) (0)
- M127. Baseline Psychopathology as Predictors of Functional Outcome in Attenuated and Early First Episode Psychosis. (2017) (0)
- 2.2 Risk of Violent Behavior in Young Adults at Clinical High Risk for Psychosis From the North American Prodrome Longitudinal Studies Consortium (2022) (0)
- Bipolar Prodrome Symptom Scale--Prospective (2019) (0)
- P583. Morphometric Similarity Network Alterations in Youth at Clinical High Risk for Psychosis (2022) (0)
- Review Article Neuroprotection in emerging psychotic disorders (2007) (0)
- Family‐focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial (2021) (0)
- Substance use in youth at genetic and clinical high risk for psychosis (2022) (0)
- SOCIAL AND ROLE FUNCTIONING AS PREDICTORS OF PSYCHOSIS AND DISABILITY (2012) (0)
- Attention deficits and disruptions of frontal-striatal brain functioning in schizophrenia (1993) (0)
- 42. Heterogeneity of Neuropsychological Profiles in the Prodrome to Psychosis: An Examination of the Association Between Cognition and Clinical Outcomes in NAPLS-1 (2017) (0)
- Acknowledgement to assessors (2012) (0)
- Validation of the French version of the Global Functioning: Social and Global Functioning: Role Scales in adolescents and young adults seeking help in early intervention clinics. (2023) (0)
- Longitudinal impact of trauma in the North American Prodrome Longitudinal Study‐3 (2022) (0)
This paper list is powered by the following services:
Other Resources About Barbara A. Cornblatt
What Schools Are Affiliated With Barbara A. Cornblatt?
Barbara A. Cornblatt is affiliated with the following schools:
